project id: TCGA-LUAD; case submitter id: TCGA-05-5429; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 60; days to birth: -22066; days to death: 275; ethnicity: not reported; gender: male; race: not reported; vital status: Dead; year of birth: 1950; age at diagnosis: 22066; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 30.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lung, NOS; synchronous malignancy: No; tissue or organ of origin: Lung, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.9; longest dimension: 1.0; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-05-5429-01A-01; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent tumor nuclei: 80.0;